ALLOVIR
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases. It provides an ideal environment for ViraCyte to develop and advance its product pipeline from discovery through late-stage clinical trials. The company was founded in 2013 and headquartered in Houston, Texas.
ALLOVIR
Social Links:
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2013-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.allovir.com
Total Employee:
101+
Status:
Active
Contact:
(346)772-0319
Email Addresses:
[email protected]
Total Funding:
285.59 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Google Maps GoDaddy DNS Google Maps API AWS Global Accelerator Google Maps For Work
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - AlloVir
Invus
Invus investment in Post-IPO Equity - AlloVir
Kite Pharma
Kite Pharma investment in Post-IPO Equity - AlloVir
GMT Capital
GMT Capital investment in Post-IPO Equity - AlloVir
Redmile Group
Redmile Group investment in Post-IPO Equity - AlloVir
ElevateBio
ElevateBio investment in Post-IPO Equity - AlloVir
Gilead Sciences
Gilead Sciences investment in Post-IPO Equity - AlloVir
F2 Ventures
F2 Ventures investment in Post-IPO Equity - AlloVir
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - AlloVir
Leerink Partners
Leerink Partners investment in Series B - AlloVir
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-16 | AlloVir Announces Departure of Chief Medical Officer Augustin Melian |
Official Site Inspections
http://www.allovir.com Semrush global rank: 301.35 K Semrush visits lastest month: 211.43 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
